Blood Advances, a Journal of the American Society of Hematology, published online and open access, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences. Blood Advances will complement Blood by publishing content not currently covered including case reports, point-counterpoint discussions, and by providing forums to readily comment on published material. The electronic format of Blood Advances provides an opportunity to explore novel approaches for presentation of original content including the use of enhanced graphics, video and online discussion. Additionally, it is hoped that Blood Advances will serve as a hub for dissemination of educational and service needs by providing scholarly content and expert consultation requested by interested parties.

Acceptance of manuscripts is based on the originality or importance of the observations and investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized, and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.

Blood Advances has recently added a new scientific category for Health Services and Outcomes submissions. The journal is very interested in submissions as reflected in the definition here.

Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Health Services and Outcomes (new); Hematopoiesis and Stem Cells; Immunobiology; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.

Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal. For presubmission inquiries regarding the journal scope, please contact the Blood Advances Editorial Department and include an abstract or detailed summary for consideration.

Volume 7, Issue 1: Pages 1-194 (10 January 2023)

Volume 7, Issue 2: Pages 195-284 (24 January 2023)

Volume 7, Issue 3: Pages 285-468 (14 February 2023)

Volume 7, Issue 4: Pages 469-680 (28 February 2023)

Volume 7, Issue 5: Pages 681-876 (14 March 2023)